OncoSec Medical Inc. (ONCS) Issues Quarterly Earnings Results, Misses Estimates By $0.04 EPS
OncoSec Medical Inc. (NASDAQ:ONCS) announced its quarterly earnings results on Thursday. The company reported ($0.39) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by $0.04.
Shares of OncoSec Medical (NASDAQ:ONCS) traded up 4.19% during trading on Thursday, hitting $1.74. 185,847 shares of the company’s stock were exchanged. The stock’s 50-day moving average price is $1.72 and its 200-day moving average price is $1.84. OncoSec Medical has a 1-year low of $1.36 and a 1-year high of $4.61. The stock’s market cap is $30.69 million.
A hedge fund recently raised its stake in OncoSec Medical stock. Vanguard Group Inc. raised its stake in shares of OncoSec Medical Inc. (NASDAQ:ONCS) by 3.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 430,031 shares of the company’s stock after buying an additional 13,025 shares during the period. Vanguard Group Inc. owned approximately 2.44% of OncoSec Medical worth $705,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 7.42% of the company’s stock.
A number of brokerages have weighed in on ONCS. Rodman & Renshaw began coverage on shares of OncoSec Medical in a research note on Thursday, July 21st. They issued a “buy” rating and a $6.00 target price for the company. Maxim Group downgraded shares of OncoSec Medical to a “buy” rating and dropped their target price for the stock from $17.00 to $5.00 in a research note on Thursday, July 21st.
About OncoSec Medical
OncoSec Medical Incorporated is a biotechnology company focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer. The Company’s portfolio includes biologic immunology therapeutic product candidates intended to treat a range of tumor types.
Receive News & Stock Ratings for OncoSec Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OncoSec Medical Inc. and related stocks with our FREE daily email newsletter.